Chagas Cardiomyopathy clinical trials

The registry lists 17 studies for Chagas Cardiomyopathy across 4 countries. 2 are recruiting or about to start. 16 of them are mainly about Chagas Cardiomyopathy (how this is decided). Per ClinicalTrials.gov, last updated 2026-07-08.

Get an email when these change. Save the Chagas Cardiomyopathy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 11
Status unknown: 3
Recruiting: 2
Terminated: 1

Phase

Phase 3: 6
Phase 4: 2
Early Phase 1: 1
Phase 2: 1

Where

Brazil: 14
Colombia: 2
Argentina: 1
United States: 1

Who runs them

InCor Heart Institute (3) · Federal University of Minas Gerais (2) · Evandro Chagas National Institute of Infectious Disease (2) · University of Sao Paulo General Hospital (2) · Universidade Gama Filho (1) · Evandro Chagas Institute of Clinical Research (1) · Fundación Cardiovascular de Colombia (1) · University of Sao Paulo (1)

What is being tested here

Drugs under test in Chagas Cardiomyopathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Sacubitril valsartan	1	1	1
Enalapril	1	1	1
Amiodarone	0	1	2
Omega-3 fatty acid	0	0	1
Carvedilol	0	0	1
Bisoprolol	0	1	1
Granulocyte Colony-Stimulating Factor	0	1	1
Filgrastim	0	1	1

Coming up

1phase 3 study under way

0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

Of the 2 Chagas Cardiomyopathy studies recruiting now, 1 (50%) set no upper age limit and 1 (50%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	1 (50%)	1 (50%)

Across all 17 studies, recruiting or not: 59% stop at 75 or younger and 18% at 65; 12% take children; 0% are for women only and 0% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 17 of 17. search them.